Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics

Prostate cancers may reactivate a latent embryonic program called the epithelial–mesenchymal transition (EMT) during the development of metastatic disease. Through EMT, tumors can develop a mesenchymal phenotype similar to cancer stem cell traits that contributes to metastasis and variation in thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaves, Luiz Paulo, Melo, Camila Morais, Saggioro, Fabiano Pinto, dos Reis, Rodolfo Borges, Squire, Jeremy Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701270/
https://www.ncbi.nlm.nih.gov/pubmed/34946849
http://dx.doi.org/10.3390/genes12121900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701270/
https://www.ncbi.nlm.nih.gov/pubmed/34946849
http://dx.doi.org/10.3390/genes12121900

Ejemplares similares